“Development of a Sustained-Release Oral Tablet of Tyrosine Kinase Inhibitor Imatinib Using Full Factorial Design” (2024) Dhaka University Journal of Pharmaceutical Sciences, 23(2), pp. 135–143. doi:10.3329/dujps.v23i2.78571.